Search

everythinglearnresearchcommunity

for

Search:↓

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Some congenital hair disorders improve in childhood or with treatments like minoxidil and retinoids, while others like Netherton syndrome and trichothiodystrophy have a poor prognosis.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

Stress activates a special function of the Vitamin D receptor with the help of c-Jun, which can also prevent cell death.

Stem cell therapy could help regenerate inner ear hair cells to treat hearing loss.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

The conclusion is that the nuclear lamina and LINC complex in skin cells respond to mechanical signals, affecting gene expression and cell differentiation, which is important for skin health and can impact skin diseases.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

MicroRNAs play a crucial role in skin and hair health, affecting everything from growth to aging, and could potentially be used in treating skin diseases.

The guidelines ensure accurate genetic testing and reporting for 21-hydroxylase deficiency.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

A specific gene mutation causes woolly hair and hair loss.

Certain genetic variants may increase the risk of developing PCOS.

A gene mutation in mice causes permanent hair loss and skin issues.

Genetic variants in PDE6H and LPAR6 cause vision impairment and hair loss in two Pakistani brothers.

The ZIP13 variant is linked to abnormal hair quality.

Genes related to calcium signaling and lipid metabolism are important for curly hair in Mangalitza pigs.

Genetic variants can affect valproic acid's effectiveness, side effects, and levels in epilepsy treatment.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Certain genetic variations in the FST gene are linked to better wool quality in Chinese Merino sheep.

A mouse gene mutation increases the risk of skin cancer.

Certain changes in the VEGF gene can increase or decrease the risk of polycystic ovary syndrome.

The ABCA4 gene protects hair follicle stem cells from toxic vitamin A byproducts.

A gene deletion in mice causes weak protein, immune issues, hair loss, airway problems, and wasting disease.

Gene expression in milk cells and blood can help detect illegal rbST use in cows.

Gene therapy shows promise for healing chronic wounds but needs more research to overcome challenges.

A WNT10A gene mutation leads to ectodermal dysplasia by disrupting cell growth and differentiation.

People with the same genetic mutation for Woodhouse-Sakati syndrome can have different symptoms.